'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
FOX NEWS: 'First-in-class' precision cancer drug shows promising results in Phase I trial
'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
0 comments:
Post a Comment